Eagle Pharma $9.5M Investor Deal Gets Final OK
A $9.5 million settlement resolving claims that Eagle Pharmaceuticals Inc. and its former executives carried out a fraudulent "channel stuffing" scheme to inflate the revenue of one of the company's brand-name...To view the full article, register now.
Already a subscriber? Click here to view full article